Major techs and semiconductor companies give up on early-trading gains after the report stating that U.S. Commerce Department plans to revoke waivers allowing South Korean and Taiwanese chipmakers (ex. Samsung, SK Hynix, TSMC) to export American semiconductor equipment to their factories in China without individual licenses.
The Philadelphia Semiconductor Index is down 0.8% after the report release. Lam Research's shares took the biggest hit (-3.13%), with other key players also trading in the red (Nvidia: -1.1%; Intel: -1.7%, Broadcom: -1.6%, Qualcomm: -1.3%).
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThe move aims to tighten controls on U.S. technology transfers to China, mirroring China’s export restrictions on rare-earth materials, and reflects a broader national-security push to limit China’s technological advances. Diplomatically, this decision risks undermining the recent fragile U.S.–China trade truce and straining relations with key U.S. allies South Korea and Taiwan.
The Chinese fabs affected produce essential chips used in cars, electronics, and other goods, though generally not the most advanced technologies. While immediate shutdowns are unlikely, tighter restrictions could disrupt operations and global supply chains over time. The companies may seek individual licenses or shift to Japanese and European suppliers, but internal U.S. government disagreement and fears of empowering Chinese rivals add complexity to the policy’s impact.
The US100 fell sharply below key resistance levels, delaying any potential recovery toward February’s all-time highs. Source: xStation5
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
